Faculty Information - HIRAO Maki | Daito Bunka University

（Last updated : 2025-08-15 17:48:03）

HIRAO Maki

Department Daito Bunka University Faculty of Sports and Health Science Department of Health Science

Daito Bunka University Graduate School Graduate School of Sports and Health Science Sports and Health Science

Job Professor

E-Mail Address

Grants-in-Aid for Scientific Research Reseacher number
10902158

researchmap Researcher code
R000034596

Present specialized field
Sports Medicine, Clinical pharmacy

Academic background
1.	1993/09～1994/05	Major in Chemistry College of Liberal Arts, Boston University, Massachusetts, U.S.A.,
2.	1997/05～1998/05	Doctorial Population Health & Reproduction Program in Physiology, University of California, Davis, U.S.A.,
3.	1990/10～1993/06	Dimond High School, Anchorage, Alaska, U.S.A. Graduated
4.	1994/05～1997/05	Major in Biochemistry College of Liberal Arts, Tufts University, Medford, Massachusetts, U.S.A., Graduated
5.	1998/06～2003/12	Doctorial Program in Biomolecular Structure and Design, University of Washington, Seattle, Washington, U.S.A., Finished
Display All（6）

Business career
1.	1996/09 ～ 1996/11	Teaching Assistant Tufts University, Cells and Organisms Laboratory,
2.	1998/06 ～ 2003/12	Research Assistant University of Washington/Fred Hutchinson Cancer Research Center, Clinical Research Division and Public Health Sciences Division,
3.	2000/03 ～ 2000/06	Teaching Assistant University of Washington, Cell Biology, Molecular Biology of Disease,
4.	2009/04 ～ 2011/03	Tokyo Saiseikai Central Hospital
5.	2011/04 ～ 2015/03	Tokyo Saiseikai Central Hospital Department of Medicine
Display All（6）

Academic conference
1.	2013/02 ～	International Myeloma Society
2.	2024/05 ～	Japan Society of Golf Sciences

Books and Papers
1.	Papers	Association of health literacy with quality of life and health outcomes among school-age children in Japan: A cross-sectional study PLOS ONE 20 (5),pp.e0324456 (Co-authored) 2025/05/20
2.	Papers	Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells Pharmaceuticals 16,pp.1367-1382 (Co-authored) 2023/09
3.	Papers	Factors Associated with Refraining from Health Checkups during the COVID-19 Pandemic in Japan Healthcare 11 (17),pp.2385-2397 (Co-authored) 2023/08
4.	Papers	Novel Aldosterone Antagonists in Hypertension and Diabetic Kidney Disease Japanese Pharmacology & Therapeutics,pp.1071-1087 (Co-authored) 2023/07
5.	Papers	GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase Cancer medicine 12 (8),pp.9749-9759 (Co-authored) 2023/02
Display All（21）

Academic conference presentation
1.	2024/05	Result of the questionnaire survey on diversity, equity, and inclusion (DE & I) by the diversity promotion committee of the Japanese Society of Myeloma
2.	2020/07	A Hereditary bleeding disorder caused by a novel homozygous mutation of thrombomodulin gene (The Congress of the International Society on Thrombosis and Hemostasis)
3.	2018/12	Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma (the 60th American Society of Hematology Annual Meeting and Exposition Annual Meeting)
4.	2018/07	Identification of clonal evolution of CSF3R-mutated chronic neutrophilic leukemia using mutational screens of SETBP1, ASXL1 and SRSF2 (the 9th JSH International Symposium)
5.	2003/03	Inhibitors of Sir2p: evaluation of Splitomicin analogues (the 225th American Chemical Society National Meeting)
Display All（6）

Research topic, funded research, and Grants-in-Aid for Scientific Research
1.	1996/06 ～ 1996/08	Howard Hughes Medical Institute Undergraduate Research Fellows (Tufts University), Localization of Allin Lyase mRNA in the Garlic Clove by in situ Hybridization with Digoxigenin-Riboprobes Joint Research inside the organization